Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (961-970 of 1,066) with videos related to

Pageof 107
Sort By:
Genes, Chromosomes & Cancer|December 8, 2007
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patientsKenneth D Swanson, Jordan M Winter, Marcelo Reis, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B studyGuido Marcucci, Claudia D Baldus, Amy S Ruppert, et al.
Bioorganic Chemistry|June 24, 2025
Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffoldGiulia Bononi, Francesca Gado, Samuele Masoni, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyGuido Marcucci, Kati Maharry, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Blood|August 31, 2018
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and functionSteven D Scoville, Ansel P Nalin, Luxi Chen, et al.
Cancer Research|July 22, 2024
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and MetastasisCamino Bermejo-Rodriguez, Joaquín Araos Henríquez, Giuseppina Caligiuri, et al.
Pageof 107

Showing results (961-970 of 1,066) with videos related to

Sort By:
Pageof 107
Genes, Chromosomes & Cancer|December 8, 2007
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patientsKenneth D Swanson, Jordan M Winter, Marcelo Reis, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B studyGuido Marcucci, Claudia D Baldus, Amy S Ruppert, et al.
Bioorganic Chemistry|June 24, 2025
Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffoldGiulia Bononi, Francesca Gado, Samuele Masoni, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyGuido Marcucci, Kati Maharry, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Blood|August 31, 2018
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and functionSteven D Scoville, Ansel P Nalin, Luxi Chen, et al.
Cancer Research|July 22, 2024
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and MetastasisCamino Bermejo-Rodriguez, Joaquín Araos Henríquez, Giuseppina Caligiuri, et al.
Pageof 107